Isaac Barchas's most recent trade in Immunome Inc was a trade of 83,094 Common Stock done at an average price of $24.1 . Disclosure was reported to the exchange on July 6, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Immunome Inc | Isaac Barchas | Director | Sale of securities on an exchange or to another person at price $ 24.11 per share. | 06 Jul 2026 | 83,094 | 125,410 | - | 24.1 | 2,003,396 | Common Stock |
| Immunome Inc | Isaac Barchas | Director | Sale of securities on an exchange or to another person at price $ 24.20 per share. | 06 Jul 2026 | 16,906 | 108,504 | - | 24.2 | 409,125 | Common Stock |
| Immunome Inc | Isaac Barchas | Director | Sale of securities on an exchange or to another person at price $ 21.12 per share. | 30 Jun 2026 | 101,050 | 308,504 | - | 21.1 | 2,134,176 | Common Stock |
| Immunome Inc | Isaac Barchas | Director | Sale of securities on an exchange or to another person at price $ 22.35 per share. | 30 Jun 2026 | 75,665 | 232,839 | - | 22.4 | 1,691,113 | Common Stock |
| Immunome Inc | Isaac Barchas | Director | Sale of securities on an exchange or to another person at price $ 23.33 per share. | 30 Jun 2026 | 24,335 | 208,504 | - | 23.3 | 567,736 | Common Stock |
| Immunome Inc | Isaac Barchas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 9,897 | 9,897 | - | - | Director Stock Option (right to buy) | |
| Immunome Inc | Isaac Barchas | Director | Sale of securities on an exchange or to another person at price $ 21.72 per share. | 22 Dec 2025 | 371,949 | 2,042,432 | - | 21.7 | 8,078,732 | Common Stock |
| Immunome Inc | Isaac Barchas | Director | Sale of securities on an exchange or to another person at price $ 22.34 per share. | 22 Dec 2025 | 11,251 | 2,031,181 | - | 22.3 | 251,347 | Common Stock |
| Immunome Inc | Isaac Barchas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 18,864 | 18,864 | - | - | Director Stock Option (right to buy) | |
| Immunome Inc | Isaac Barchas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 11,333 | 11,333 | - | - | Stock option (right to buy) |